Treatment with Alemtuzumab Leads to Durable Benefits in Patients with Multiple Sclerosis

Article Information

DOI 
http://dx.doi.org/10.1177/155989771406004
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Maria Vinall
  1. Douglas L. Arnold, MD
    1. NeuroRX Research and Montreal Neurological Institute, McGill University, Montreal, Québec, Canada
View Full Text

Article usage

AbstractFullPDF
Apr 20151400
May 2015102
Jun 2015311
Jul 2015111
Aug 20151500
Sep 201512300
Oct 2015232
Nov 20157721
Total23677

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Treatment with Alemtuzumab Leads to Durable Benefits in Patients with Multiple Sclerosis
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Demyelinating Diseases Clinical Trials
Neurology
Demyelinating Diseases
Neurology Clinical Trials